AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 23524476 — intervention group
Group type: COMPARATOR
Intervention: Distraction-Free Group
Number of subjects: 32
Study 18256913 — intervention group
Group type: EXPERIMENTAL
Intervention: Supplementary support during pregnancy
Number of subjects: 1403
Study 19340730 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol
Number of subjects: 150
Study 19340730 — intervention group
Group type: COMPARATOR
Intervention: Midazolam plus meperidine
Number of subjects: 150
Study 16506872 — intervention group
Group type: EXPERIMENTAL
Intervention: High-grade mobilization techniques (HGMT)
Number of subjects: 100
Study 16506872 — intervention group
Group type: COMPARATOR
Intervention: Low-grade mobilization techniques (LGMT)
Number of subjects: 100
Study 10392645 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualified physiotherapy (QPT) - additional treatment from a qualified physiotherapist
Number of subjects: 282
Study 10392645 — intervention group
Group type: EXPERIMENTAL
Intervention: Assistant physiotherapy (APT) - additional treatment from a trained supervised assistant
Number of subjects: 282
Study 10392645 — intervention group
Group type: COMPARATOR
Intervention: Routine physiotherapy (RPT) - no additional physiotherapy
Number of subjects: 282
Study 10392645 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional treatment (QPT and APT)
Number of subjects: 282
Study 8675249 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine plus diltiazem (180 mg/d)
Number of subjects: 16
Study 8675249 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine plus verapamil (180 mg/d)
Number of subjects: 16
Study 8675249 — intervention group
Group type: COMPARATOR
Intervention: Nifedipine alone (30 mg/d)
Number of subjects: 16
Study 8675249 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine plus diltiazem
Number of subjects: 16
Study 1812599 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine
Number of subjects: 401
Study 1812599 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrimethamine-sulfadoxine (FansidarR)
Number of subjects: 401
Study 1812599 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine
Number of subjects: 401
Study 1812599 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrimethamine-sulfalene (MetakelfinR)
Number of subjects: 401
Study 6417027 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolation and decontamination procedures in laminar air flow rooms (90 patients)
Number of subjects: 182
Study 6417027 — intervention group
Group type: COMPARATOR
Intervention: Prophylactic granulocyte transfusion from a single family member (92 patients)
Number of subjects: 182
Study 31076930 — intervention group
Group type: COMPARATOR
Intervention: D1 lymphadenectomy
Number of subjects: 0
Study 31076930 — intervention group
Group type: EXPERIMENTAL
Intervention: D2 lymphadenectomy
Number of subjects: 0
Study 31076930 — intervention group
Group type: COMPARATOR
Intervention: D3 lymphadenectomy
Number of subjects: 0
Study 29649377 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity-based lifestyle intervention (3 months)
Number of subjects: 21
Study 29649377 — intervention group
Group type: COMPARATOR
Intervention: Nonintervention group (control)
Number of subjects: 21
Study 26329382 — intervention group
Group type: EXPERIMENTAL
Intervention: Modafinil (MOD) 200 mg daily for 4 weeks
Number of subjects: 27
Study 26329382 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 24797449 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS (2 mA, 20 min)
Number of subjects: 0
Study 24797449 — intervention group
Group type: EXPERIMENTAL
Intervention: Cathodal tDCS (2 mA, 20 min)
Number of subjects: 0
Study 24797449 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS (2 mA, 20 min)
Number of subjects: 0
Study 22408124 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone 30 mg daily
Number of subjects: 20
Study 22408124 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 20152611 — intervention group
Group type: EXPERIMENTAL
Intervention: AcrySof ReSTOR SA60D3 multifocal IOL
Number of subjects: 161
Study 20152611 — intervention group
Group type: COMPARATOR
Intervention: AcrySof SA60AT single‐piece monofocal IOL
Number of subjects: 161
Study 17633129 — intervention group
Group type: EXPERIMENTAL
Intervention: Mini bypass system
Number of subjects: 60
Study 17633129 — intervention group
Group type: COMPARATOR
Intervention: Conventional system
Number of subjects: 60
Study 16040091 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% bupivacaine
Number of subjects: 100
Study 16040091 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 100
Study 12183724 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum pancreatic trypsinogen and isoamylase measurements in patients with SDS
Number of subjects: 164
Study 12183724 — intervention group
Group type: EXPERIMENTAL
Intervention: CART analysis applied to patients with SDS
Number of subjects: 164
Study 12183724 — intervention group
Group type: COMPARATOR
Intervention: Control patients (not specified intervention)
Number of subjects: 164
Study 10448444 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioural therapy (CBT)
Number of subjects: 55
Study 10448444 — intervention group
Group type: COMPARATOR
Intervention: Moclobemide plus clinical management
Number of subjects: 55
Study 10448444 — intervention group
Group type: EXPERIMENTAL
Intervention: Moclobemide plus CBT
Number of subjects: 55
Study 10448444 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus CBT
Number of subjects: 55
Study 10448444 — intervention group
Group type: COMPARATOR
Intervention: Placebo plus clinical management
Number of subjects: 55
Study 7799065 — intervention group
Group type: EXPERIMENTAL
Intervention: 111In‐DTPA‐D‐Phe‐1‐octreotide
Number of subjects: 41
Study 2139791 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfilled light-cured resin
Number of subjects: 186
Study 2139791 — intervention group
Group type: EXPERIMENTAL
Intervention: Filled light-cured resin
Number of subjects: 186
Study 2139791 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-cured resins (both types)
Number of subjects: 186
Study 2139791 — intervention group
Group type: COMPARATOR
Intervention: Chemically-cured material (control)
Number of subjects: 186
Study 2139791 — intervention group
Group type: EXPERIMENTAL
Intervention: Gel form etchant
Number of subjects: 186
Study 30612116 — intervention group
Group type: EXPERIMENTAL
Intervention: Mycophenolate mofetil (MMF)
Number of subjects: 140
Study 30612116 — intervention group
Group type: COMPARATOR
Intervention: Cyclophosphamide
Number of subjects: 140
Study 28759307 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) at 25 mmHg
Number of subjects: 45
Study 28759307 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) at 35 mmHg
Number of subjects: 45
Study 28759307 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent pneumatic compression (IPC) at 45 mmHg
Number of subjects: 45
Study 26479271 — intervention group
Group type: EXPERIMENTAL
Intervention: Wire-guided endoscopic snare papillectomy (WP)
Number of subjects: 45
Study 26479271 — intervention group
Group type: COMPARATOR
Intervention: Conventional endoscopic snare papillectomy (CP)
Number of subjects: 45
Study 26479271 — intervention group
Group type: COMPARATOR
Intervention: Conventional endoscopic snare papillectomy (CP) without stents
Number of subjects: 45
Study 26479271 — intervention group
Group type: COMPARATOR
Intervention: Conventional endoscopic snare papillectomy (CP) with stents
Number of subjects: 45
Study 25131843 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive polarizing 3D display
Number of subjects: 20
Study 22381043 — intervention group
Group type: EXPERIMENTAL
Intervention: Ritonavir (300 mg twice daily for 3 days)
Number of subjects: 14
Study 20461335 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardized task‐oriented therapy with botulinum toxin injections
Number of subjects: 20
Study 20461335 — intervention group
Group type: COMPARATOR
Intervention: Standardized task‐oriented therapy without botulinum toxin injections
Number of subjects: 20
Study 17636152 — intervention group
Group type: EXPERIMENTAL
Intervention: Mental Stress (MS)
Number of subjects: 58
Study 17636152 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise (EX)
Number of subjects: 58
Study 15608311 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of DMARDs with prednisolone
Number of subjects: 195
Study 15608311 — intervention group
Group type: COMPARATOR
Intervention: Single DMARD
Number of subjects: 195
Study 12379183 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided core biopsy with a spring-loaded device
Number of subjects: 54
Study 9920517 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA-rich diet (n=15)
Number of subjects: 29
Study 9920517 — intervention group
Group type: COMPARATOR
Intervention: LA-rich diet (n=14)
Number of subjects: 29
Study 7485304 — intervention group
Group type: EXPERIMENTAL
Intervention: Active device (data revealed)
Number of subjects: 1355
Study 7485304 — intervention group
Group type: COMPARATOR
Intervention: Sham device (data concealed)
Number of subjects: 1355
Study 2078483 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination chemotherapy with cyclophosphamide, methotrexate, 5‐fluorouracil, and low‐dose prednisone (CMFp)
Number of subjects: 327
Study 2078483 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical oophorectomy followed by CMFp (Ox + CMFp)
Number of subjects: 327
Study 2078483 — intervention group
Group type: EXPERIMENTAL
Intervention: CMFp in ER+ tumors
Number of subjects: 327
Study 2078483 — intervention group
Group type: EXPERIMENTAL
Intervention: CMFp in ER- tumors
Number of subjects: 327
Study 380909 — intervention group
Group type: EXPERIMENTAL
Intervention: Amineptine (200 mg per day)
Number of subjects: 50
Study 380909 — intervention group
Group type: COMPARATOR
Intervention: Trimipramine (75 mg per day)
Number of subjects: 50
Study 31282037 — intervention group
Group type: EXPERIMENTAL
Intervention: Anesthetic cream applied after cryotherapy treatment
Number of subjects: 0
Study 31282037 — intervention group
Group type: COMPARATOR
Intervention: Cryotherapy treatment without anesthetic cream
Number of subjects: 0
Study 28402353 — intervention group
Group type: EXPERIMENTAL
Intervention: Connective tissue graft
Number of subjects: 0
Study 28402353 — intervention group
Group type: COMPARATOR
Intervention: Guided bone regeneration
Number of subjects: 0
Study 25906791 — intervention group
Group type: EXPERIMENTAL
Intervention: Otago Exercise Programme (OEP)
Number of subjects: 319
Study 25906791 — intervention group
Group type: EXPERIMENTAL
Intervention: Falls Exercise Management (FaME)
Number of subjects: 319
Study 25906791 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 319
Study 22350098 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured interactive group education program
Number of subjects: 150
Study 22350098 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 150
Study 21817043 — intervention group
Group type: EXPERIMENTAL
Intervention: Updating training for 5 weeks
Number of subjects: 0
Study 21817043 — intervention group
Group type: COMPARATOR
Intervention: Control condition (not specified)
Number of subjects: 0
Study 19350376 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic horseback riding (12 weeks)
Number of subjects: 34
Study 19350376 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 34
Study 17541571 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg oral M6G
Number of subjects: 8
Study 17541571 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg oral M6G
Number of subjects: 8
Study 17541571 — intervention group
Group type: COMPARATOR
Intervention: 30 mg oral morphine
Number of subjects: 8
Study 17541571 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol and sulfasalazine coadministered with M6G
Number of subjects: 8
Study 15579192 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine oestrogens (CEE) 0.625 mg daily + Desogestrel (DG) 75 microg
Number of subjects: 34
Study 15579192 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine oestrogens (CEE) 0.625 mg daily + Medroxyprogesterone (MP) 10 mg
Number of subjects: 34
Study 15579192 — intervention group
Group type: EXPERIMENTAL
Intervention: Conjugated equine oestrogens (CEE) 0.625 mg daily + Norethisterone (NE) 1 mg
Number of subjects: 34
Study 15579192 — intervention group
Group type: COMPARATOR
Intervention: Conjugated equine oestrogens (CEE) 0.625 mg daily
Number of subjects: 34
Study 11764019 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.3 mg/kg methylphenidate (MPH)
Number of subjects: 137
Study 11764019 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 137
Study 9757170 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg/d, increased to 100 mg/d if uncontrolled after 6 weeks
Number of subjects: 302
Study 9757170 — intervention group
Group type: EXPERIMENTAL
Intervention: Losartan 50 mg/d + Hydrochlorothiazide 12.5 mg/d if uncontrolled after 6 weeks
Number of subjects: 302
Study 9757170 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine 5 mg/d, increased to 10 mg/d if uncontrolled after 6 weeks
Number of subjects: 302
Study 9757170 — intervention group
Group type: COMPARATOR
Intervention: Losartan 50 mg/d
Number of subjects: 302
Study 9757170 — intervention group
Group type: EXPERIMENTAL
Intervention: All regimens
Number of subjects: 302
Study 9757170 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 302
Study 9050473 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic linear salpingotomy with hCG dynamics analysis
Number of subjects: 60
Study 9050473 — intervention group
Group type: COMPARATOR
Intervention: Laparoscopic linear salpingotomy (control group)
Number of subjects: 60
Study 3346634 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental group (home visits)
Number of subjects: 198
Study 3346634 — intervention group
Group type: COMPARATOR
Intervention: Control group (office-based care)
Number of subjects: 198
Study 30275398 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional supplementation combined with cognitive stimulation (fortified milk powder and daily learning activities)
Number of subjects: 0
Study 30275398 — intervention group
Group type: COMPARATOR
Intervention: Unfortified milk powder (control group)
Number of subjects: 0
Study 28072453 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstainers at 6 months
Number of subjects: 1061
Study 28072453 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-risk drinkers at 6 months
Number of subjects: 1061
Study 28072453 — intervention group
Group type: COMPARATOR
Intervention: Heavy drinkers at 6 months
Number of subjects: 1061
Study 28072453 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstainers and low-risk drinkers at 6 months
Number of subjects: 1061
Study 28072453 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-risk drinkers and abstainers
Number of subjects: 1061
Study 25527746 — intervention group
Group type: EXPERIMENTAL
Intervention: Bariatric surgery
Number of subjects: 2010
Study 25527746 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 2010
Study 23142798 — intervention group
Group type: EXPERIMENTAL
Intervention: Withania somnifera (2 g every 8 hours during chemotherapy)
Number of subjects: 100
Study 23142798 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (control group)
Number of subjects: 100
Study 21620782 — intervention group
Group type: EXPERIMENTAL
Intervention: Target inhalation mode (TIM)
Number of subjects: 20
Study 21620782 — intervention group
Group type: COMPARATOR
Intervention: Tidal breathing mode (TBM)
Number of subjects: 20
Study 18464021 — intervention group
Group type: EXPERIMENTAL
Intervention: Estetrol 0.1 mg
Number of subjects: 32
Study 18464021 — intervention group
Group type: EXPERIMENTAL
Intervention: Estetrol 1 mg
Number of subjects: 32
Study 18464021 — intervention group
Group type: EXPERIMENTAL
Intervention: Estetrol 10 mg
Number of subjects: 32
Study 18464021 — intervention group
Group type: EXPERIMENTAL
Intervention: Estetrol 100 mg
Number of subjects: 32
Study 18464021 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 32
Study 17320009 — intervention group
Group type: EXPERIMENTAL
Intervention: SMART BAG resuscitator
Number of subjects: 0
Study 17320009 — intervention group
Group type: COMPARATOR
Intervention: Traditional bag-valve-mask (Easy Grip) resuscitator
Number of subjects: 0
Study 17320009 — intervention group
Group type: EXPERIMENTAL
Intervention: Both devices
Number of subjects: 0
Study 14967156 — intervention group
Group type: EXPERIMENTAL
Intervention: Capillary plasma glucose measurements
Number of subjects: 350
Study 14967156 — intervention group
Group type: COMPARATOR
Intervention: Venous plasma glucose measurements
Number of subjects: 350
Study 11237274 — intervention group
Group type: EXPERIMENTAL
Intervention: Severe Traumatic Brain Injury Outcome Interview
Number of subjects: 0
Study 11237274 — intervention group
Group type: COMPARATOR
Intervention: Glasgow Outcome Scale
Number of subjects: 0
Study 11237274 — intervention group
Group type: COMPARATOR
Intervention: Disability Rating Scale
Number of subjects: 0
Study 9210746 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly maintenance interpersonal psychotherapy with placebo (N = 19)
Number of subjects: 47
Study 9210746 — intervention group
Group type: COMPARATOR
Intervention: Placebo and supportive medication clinic without interpersonal psychotherapy (N = 28)
Number of subjects: 47
Study 9210746 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance interpersonal psychotherapy (N = 9)
Number of subjects: 47
Study 9210746 — intervention group
Group type: COMPARATOR
Intervention: Medication clinic without interpersonal psychotherapy (N = 12)
Number of subjects: 47
Study 7955992 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking (determined by history and urine cotinine levels)
Number of subjects: 169
Study 7955992 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarette smoking
Number of subjects: 169
Study 7955992 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean HbA1c during follow-up
Number of subjects: 169
Study 7955992 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean HbA1c since diagnosis
Number of subjects: 169
Study 7955992 — intervention group
Group type: EXPERIMENTAL
Intervention: Mean blood pressure, lipoprotein(a), and apolipoprotein B
Number of subjects: 169
Study 3297482 — intervention group
Group type: EXPERIMENTAL
Intervention: Neo Sampoon vaginal tablets (60 mg menfegol)
Number of subjects: 349
Study 3297482 — intervention group
Group type: COMPARATOR
Intervention: Emko vaginal foam (8.0% nonoxynol-9)
Number of subjects: 349
Study 31086947 — intervention group
Group type: EXPERIMENTAL
Intervention: Escherichia coli-produced bivalent HPV-16/18 vaccine
Number of subjects: 7372
Study 31086947 — intervention group
Group type: COMPARATOR
Intervention: Control (hepatitis E vaccine)
Number of subjects: 7372
Study 26810047 — intervention group
Group type: EXPERIMENTAL
Intervention: Pictorial mnemonic-strategy approach
Number of subjects: 8
Study 26810047 — intervention group
Group type: COMPARATOR
Intervention: Children's own preferred learning methods
Number of subjects: 8
Study 26799126 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient self-testing (PST)
Number of subjects: 2922
Study 26799126 — intervention group
Group type: COMPARATOR
Intervention: Usual ACC care
Number of subjects: 2922
Study 25618966 — intervention group
Group type: EXPERIMENTAL
Intervention: Dendritic cells (DCs) plus ginseng polysaccharides (GPS) administered thoracoscopically, once a week, 4 times for 30 days.
Number of subjects: 96
Study 25618966 — intervention group
Group type: COMPARATOR
Intervention: Control group treated with dendritic cells (DCs) alone.
Number of subjects: 96
Study 23778443 — intervention group
Group type: EXPERIMENTAL
Intervention: Driving Simulator (DS)
Number of subjects: 40
Study 23778443 — intervention group
Group type: COMPARATOR
Intervention: Control Group
Number of subjects: 40
Study 20453655 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin (2 mg bolus injection)
Number of subjects: 24
Study 20453655 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 18624605 — intervention group
Group type: EXPERIMENTAL
Intervention: Adaptation exercise (encouraged to consider their ability to adapt)
Number of subjects: 1117
Study 18624605 — intervention group
Group type: COMPARATOR
Intervention: No adaptation exercise (control group)
Number of subjects: 1117
Study 16652085 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral prednisone for 2 weeks followed by intranasal budesonide for 12 weeks (Group A, n = 63)
Number of subjects: 84
Study 16652085 — intervention group
Group type: COMPARATOR
Intervention: No steroid treatment (Group B, n = 21)
Number of subjects: 84
Study 12651643 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberalized fasting (Group L): formula fasted for 4-6 hours before surgery
Number of subjects: 97
Study 12651643 — intervention group
Group type: COMPARATOR
Intervention: Traditional fasting (Group T): clear liquids up to 2 hours and formula fasted for 8 hours
Number of subjects: 97
Study 12651643 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (L and T)
Number of subjects: 97
Study 10092561 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular weekly aerobic training programme, three times a week for 12 months
Number of subjects: 124
Study 10092561 — intervention group
Group type: COMPARATOR
Intervention: Matched controls who did not receive any formal exercise training
Number of subjects: 124
Study 7743718 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen 41 min‐1 by Hudson mask during the procedure
Number of subjects: 29
Study 7743718 — intervention group
Group type: COMPARATOR
Intervention: Air (Control)
Number of subjects: 29
Study 2749124 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium benzoate
Number of subjects: 33
Study 2749124 — intervention group
Group type: EXPERIMENTAL
Intervention: Tartrazine
Number of subjects: 33
Study 2749124 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium metabisulfite
Number of subjects: 33
Study 2749124 — intervention group
Group type: COMPARATOR
Intervention: Placebo (lactose)
Number of subjects: 33
Study 971031 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate hydrochloride
Number of subjects: 0
Study 971031 — intervention group
Group type: EXPERIMENTAL
Intervention: Thioridazine hydrochloride
Number of subjects: 0
Study 971031 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylphenidate/thioridazine combination
Number of subjects: 0
Study 971031 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0